Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BioMarin Pharmaceutical Inc.(BMRN) | 175,000 | 273,533 | +98,533 | $15.28M | $22.52M | 6.86% | +$7.24M |
| Merck & Co., Inc.(MRK) | 0 | 175,600 | +175,600 | $0 | $21.74M | 6.63% | +$21.74M |
| Gilead Sciences, Inc.(GILD) | 265,436 | 292,959 | +27,523 | $19.44M | $20.10M | 6.13% | +$656.7K |
| Amgen Inc.(AMGN) | 0 | 64,201 | +64,201 | $0 | $20.06M | 6.11% | +$20.06M |
| Royalty Pharma plcCL A(RPRX) | 411,540 | 692,300 | +280,760 | $12.50M | $18.26M | 5.56% | +$5.76M |
| Biogen Inc.(BIIB) | 52,000 | 76,726 | +24,726 | $11.21M | $17.79M | 5.42% | +$6.57M |
| Kenvue Inc.(KVUE) | 0 | 960,400 | +960,400 | $0 | $17.46M | 5.32% | +$17.46M |
| Insmed Incorporated(INSM) | 227,337 | 227,637 | +300 | $6.17M | $15.25M | 4.65% | +$9.08M |
| Legend Biotech CorporationADS(LEGN) | 79,830 | 343,130 | +263,300 | $4.48M | $15.20M | 4.63% | +$10.72M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 365,000 | +365,000 | $0 | $15.00M | 4.57% | +$15.00M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,135,710 | 911,900 | -223,810 | $16.02M | $14.82M | 4.52% | -$1.21M |
| Sarepta Therapeutics, Inc.(SRPT) | 94,379 | 89,379 | -5,000 | $12.22M | $14.12M | 4.30% | +$1.90M |
| Cytokinetics, Incorporated(CYTK) | 0 | 236,900 | +236,900 | $0 | $12.84M | 3.91% | +$12.84M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 2,105,459 | 1,975,298 | -130,161 | $10.70M | $12.21M | 3.72% | +$1.51M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 120,185 | 201,497 | +81,312 | $8.19M | $10.88M | 3.32% | +$2.69M |
| Arcellx Inc COMMON STOCK | 107,000 | 187,000 | +80,000 | $7.44M | $10.32M | 3.15% | +$2.88M |
| Avadel Pharmaceuticals Plc | 541,926 | 733,001 | +191,075 | $9.15M | $10.31M | 3.14% | +$1.15M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 0 | 295,771 | +295,771 | $0 | $8.92M | 2.72% | +$8.92M |
| Avantor, Inc.(AVTR) | 0 | 400,000 | +400,000 | $0 | $8.48M | 2.58% | +$8.48M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 230,000 | +230,000 | $0 | $8.32M | 2.54% | +$8.32M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 311,700 | +311,700 | $0 | $7.90M | 2.41% | +$7.90M |
| Ionis Pharmaceuticals, Inc.(IONS) | 289,366 | 160,166 | -129,200 | $12.54M | $7.63M | 2.33% | -$4.91M |
| Enliven Therapeutics Inc | 0 | 222,985 | +222,985 | $0 | $5.21M | 1.59% | +$5.21M |
| Pfizer Inc.(PFE) | 0 | 185,200 | +185,200 | $0 | $5.18M | 1.58% | +$5.18M |
| Evolus, Inc.(EOLS) | 0 | 465,300 | +465,300 | $0 | $5.05M | 1.54% | +$5.05M |
| Perrigo Company plcSHS(PRGO) | 322,114 | 100,000 | -222,114 | $10.37M | $2.57M | 0.78% | -$7.80M |
| Acadia Pharmaceuticals Inc | 658,409 | 0 | -658,409 | $12.17M | $0 | — | -$12.17M |
| Agios Pharmaceuticals, Inc.(AGIO) | 288,580 | 0 | -288,580 | $8.44M | $0 | — | -$8.44M |
| Bristol-Myers Squibb Company(BMY) | 446,900 | 0 | -446,900 | $24.24M | $0 | — | -$24.24M |
| Cabaletta Bio, Inc.(CABA) | 157,964 | 0 | -157,964 | $2.69M | $0 | — | -$2.69M |
| Eli Lilly and Company(LLY) | 11,040 | 0 | -11,040 | $8.59M | $0 | — | -$8.59M |
| Exelixis, Inc.(EXEL) | 398,762 | 0 | -398,762 | $9.46M | $0 | — | -$9.46M |
| Halozyme Therapeutics, Inc.(HALO) | 255,049 | 0 | -255,049 | $10.38M | $0 | — | -$10.38M |
| Kyverna Therapeutics, Inc.(KYTX) | 166,514 | 0 | -166,514 | $4.14M | $0 | — | -$4.14M |
| Pliant Therapeutics, Inc.(PLRX) | 194,119 | 0 | -194,119 | $2.89M | $0 | — | -$2.89M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 16,360 | 0 | -16,360 | $15.75M | $0 | — | -$15.75M |
| Viridian Therapeutics, Inc.(VRDN) | 278,638 | 0 | -278,638 | $4.88M | $0 | — | -$4.88M |